Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 3,900 shares of the business’s stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $15.18, for a total value of $59,202.00. Following the transaction, the chief executive officer directly owned 154,548 shares in the company, valued at $2,346,038.64. This trade represents a 2.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The shares were sold at an average price of $15.21, for a total value of $12,168.00.

Afya Price Performance

Shares of AFYA opened at $14.75 on Monday. Afya Limited has a 52-week low of $13.00 and a 52-week high of $19.90. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21. The stock has a fifty day simple moving average of $14.39 and a two-hundred day simple moving average of $14.74. The company has a market capitalization of $1.38 billion, a PE ratio of 10.10, a price-to-earnings-growth ratio of 0.66 and a beta of 0.52.

Afya (NASDAQ:AFYA) last announced its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The firm had revenue of $147.08 million for the quarter, compared to analysts’ expectations of $174.74 million. As a group, equities analysts forecast that Afya Limited will post 1.52 EPS for the current year.

Afya Dividend Announcement

The company also recently announced an annual dividend, which will be paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th will be issued a $0.656 dividend. This represents a yield of 433.0%. The ex-dividend date is Wednesday, March 25th. Afya’s payout ratio is presently 45.21%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AFYA. Zacks Research upgraded shares of Afya from a “strong sell” rating to a “hold” rating in a report on Monday, March 9th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $22.00 price objective (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. UBS Group reissued a “neutral” rating and set a $16.00 target price (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Finally, Bank of America downgraded Afya from a “buy” rating to a “neutral” rating and reduced their target price for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. One investment analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.30.

Institutional Investors Weigh In On Afya

Several institutional investors and hedge funds have recently modified their holdings of the company. Doma Perpetual Capital Management LLC lifted its stake in Afya by 50.6% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock worth $13,910,000 after acquiring an additional 299,419 shares in the last quarter. Swedbank AB grew its position in Afya by 170.3% in the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after acquiring an additional 119,200 shares in the last quarter. SPX Gestao de Recursos Ltda purchased a new stake in Afya during the third quarter worth about $2,895,000. State Street Corp increased its stake in Afya by 25.8% during the fourth quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after purchasing an additional 26,005 shares during the period. Finally, GSA Capital Partners LLP lifted its position in shares of Afya by 45.5% during the third quarter. GSA Capital Partners LLP now owns 89,747 shares of the company’s stock worth $1,400,000 after purchasing an additional 28,053 shares in the last quarter. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.